The utility of a rapid screening tool for depression and HIV dementia amongst patients with low CD4 counts- A preliminary report

African Journal of Psychiatry (South Africa)

Volumn 11, Issue 4, 2008, Pages 282-286

  Singh, D ^a   Sunpath, H ^b   John, S ^b   Eastham, L ^b   Gouden, R ^b  

^a SOUTH AFRICAN MEDICAL RESEARCH COUNCIL   (South Africa)

^b MCCORD HOSPITAL   (South Africa)

Author keywords

Dementia; Depression; HIV neuro cognitive deficits; Screening

Indexed keywords

CD4 ANTIGEN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; CENTER FOR EPIDEMIOLOGICAL STUDIES DEPRESSION SCALE; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITIVE DEFECT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DIAGNOSTIC VALUE; FEMALE; HUMAN; INTERNATIONAL HUMAN IMMUNODEFICIENCY VIRUS DEMENTIA SCALE; MALE; NEUROPSYCHOLOGICAL TEST; PILOT STUDY; PREDICTION; PSYCHOLOGICAL RATING SCALE; SENSITIVITY AND SPECIFICITY; TASK PERFORMANCE;

EID: 69949085952     PISSN: 19948220     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Prince M, Patel V, Saxena S, Maj M, Maselko J, Phillips M et al. No health without mental health. Lancet 2007; published online Sept 4. D01:10.1016/S0140-636(07)61238-0.
2. Lekovics JR, Hamburger ME, Vlahov D, et al. Mortality, CD4 cell count decline, and depressive symtoms among HIV- seropositive women: longitudinal analysis from the HIV Epidemiology Research Study. JAMA 2001; 285: 1466-74
3. Cook JA, Grey D, Burke J, Cohen MH, Gurtman AC, Richardson JL et al. Depressive symptoms and AIDS related mortality among a multi site cohort of HIV positive women. Am J Public Health 2004; 94: 1133-40
4. Leserman J, Jackson ED, Petitto JM, et al. Progression to AIDS: The effects of stress, depressive symptoms, and social support. Psychosomat Med 1995;61:397-406.
5. Wilkie FL, Goodkin K, Eisdorfer C, Feaster D, Morgan R, Fletcher MA et al. Mild Cognitive impairment and risk of mortality in HIV -1 infection. J Neuropsychiatry Clin Neurosci 1998; 10 (2): 125-32
6. Paterson DL, Swindells S, Mohr J, Brester EN, Vergis C, Squier MM et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med 2000; 133: 21-30
7. Hinkin CH, Hardy DJ, Mason KI, Castellon SA, Durvasula RS, Lam MN et al. Medication adherence in HIV-infected adults: effects of patient age, cognitive stauts, and substance abuse. AIDS 2004; 18 (suppl 1): S19-25
8. Collins PY, Holman Ar, Freeman MC, Patel V. What is the relevance of mental health to HIV/AIDS care and treatment programs in developing countries? A systematic review. AIDS 2006; 20: 1571-82
9. Chander G, Himmelhoch S, Moore RD. Substance abuse and psychiatric disorders in HIV positive patients: epidemiology and impact on antiretroviral therapy. Drugs 2006; 66: 769-89
10. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington, DC, American Psychiatric Association, 1994
11. Antinori G, Arendt JT, Becker BJ, Brew DA, Byrd M, Cherner DB et al Updated research nosology for HIV-associated neurocognitive disorders. Neurology 2007;69:1789-1799
12. WHO. WHO Case definitions of HIV for surveillance and revised clinical staging and immunological classification of HIV-related disease in adults and children. 2006. Geneva, WHO. Ref Type: Report
13. Janssen, R.S Nomenclature and research case definitions for neurological manifestations of human immunodeficiency virus type-1 (HIV-1) infection. Report of a Working Group in the American Academy of Neurology AIDS Task Force; 1991; 41; 777-785.
14. Sacktor NC, Wong M, Nakasujja N, Skolasky RL, Selnes OA, Musisi S et al. The International HIV Dementia Scale: a new rapid screening test for HIV dementia. AIDS 2005; 19: 1367-1374.
15. Folstein MF, Folstein SE, McHugh PR. Mini Mental State: A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189-198
16. McArthur JC. Neurologic Manifestations of AIDS. Medicine (Balt) 1987; 66: 4070-437
17. Power C, Selnes OA, Grim JA, McArthur JC. The HIV Dementia Scale.: a rapid screening test. J AIDS 1995; 8: 273-278
18. Davis HF, Skolasky RL Jr, Selnes OA, Burgess DM, McArthur JC. Assessing HIV-associated dementia: modified HIV dementia scale versus the Grooved Pegboard. AIDS Read 2002; 12: 29-31, 38
19. Sacktor N C, Wong M, Nakasujja N, Skolasky RL, Selnes OA et al. AIDS September 2, 2005 19(13):1367-1374
20. Antelman G, Kaaya S, Wei R, Mbwambo J, Msamanga G, Gernard I et al. Depressive symptoms increase risk of HIV disease progression and mortality among women in Tanzania. J Acquir Immune Defic Syndr 2007; 44: 470-477.
21. Radloff LS.The CES-D Scale: A self-report depression scale for research in the general population. Applied Psychological Measurement 1 1977, 385-401.
22. Meyer L, Smit J, Le Roux I, Parker S, Stein DJ and Seedat S. Common mental disorders among HIV-infected individuals in South Africa: prevalence, predictors, and validation of brief psychiatric rating scales. AIDS Patient care and STDs 2008; 22: 147-158.
23. Vitiello B, Goodkin K, Ashtana D, Shapshak P, Atkinson JH et al HIV-1 RNA concentration and cognitive performance in a cohort of HIV-positive people. AIDS 2007; 21(11):1415-1422.
24. Gilbody S, House AO, Sheldon TA. Screening and case finding instruments for depression. Cochrane Database of Systematic Reviews 2005, Issue 4. Art. No.: CD002792. DOI: 10.1002/ 14651858.CD002792.pub2
25. UNAIDS. 2007 Aids Epidemic Update. Geneva.